This is a preview of subscription content, log in via an institution to check access.
Notes
from a societal perspective including costs (2011 values) for promotion of the vaccine programme, vaccine dose and administration, treatment of vaccination adverse events, hospitalisation for invasive pneumococcal disease (IPD), and annual disability from IPD
programme cost of $10 per targeted minority elderly individual per year
Reference
Michaelidis CI, et al. Cost-effectiveness of a program to eliminate disparities in pneumococcal vaccination rates in elderly minority populations: an exploratory analysis. Value in Health 16: 311-7, No. 2, Mar 2013. Available from: URL: http://dx.doi.org/10.1016/j.jval.2012.11.009
Rights and permissions
About this article
Cite this article
Eliminating racial disparities in vaccination cost effective. PharmacoEcon Outcomes News 676, 5 (2013). https://doi.org/10.1007/s40274-013-0314-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0314-9